VBIZF
Price
$0.24
Change
+$0.02 (+9.09%)
Updated
May 27 closing price
Capitalization
488.02M
ZLDAF
Price
$0.28
Change
+$0.06 (+27.27%)
Updated
Jun 4 closing price
Capitalization
2.94M
Interact to see
Advertisement

VBIZF vs ZLDAF

Header iconVBIZF vs ZLDAF Comparison
Open Charts VBIZF vs ZLDAFBanner chart's image
Viva Biotech Holdings
Price$0.24
Change+$0.02 (+9.09%)
Volume$546
Capitalization488.02M
Zelira Therapeutics
Price$0.28
Change+$0.06 (+27.27%)
Volume$1K
Capitalization2.94M
VBIZF vs ZLDAF Comparison Chart
Loading...
View a ticker or compare two or three
VS
VBIZF vs. ZLDAF commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VBIZF is a Hold and ZLDAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 17, 2025
Stock price -- (VBIZF: $0.24 vs. ZLDAF: $0.28)
Brand notoriety: VBIZF and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VBIZF: 15% vs. ZLDAF: 344%
Market capitalization -- VBIZF: $488.02M vs. ZLDAF: $2.94M
VBIZF [@Biotechnology] is valued at $488.02M. ZLDAF’s [@Biotechnology] market capitalization is $2.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $342.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VBIZF’s FA Score shows that 1 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • VBIZF’s FA Score: 1 green, 4 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, both VBIZF and ZLDAF are a bad buy in the long-term.

Price Growth

VBIZF (@Biotechnology) experienced а 0.00% price change this week, while ZLDAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.54%. For the same industry, the average monthly price growth was +9.93%, and the average quarterly price growth was +7.83%.

Industries' Descriptions

@Biotechnology (-2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
VBIZF($488M) has a higher market cap than ZLDAF($2.94M). VBIZF YTD gains are higher at: 241.326 vs. ZLDAF (-27.102).
VBIZFZLDAFVBIZF / ZLDAF
Capitalization488M2.94M16,621%
EBITDAN/A-3.17M-
Gain YTD241.326-27.102-890%
P/E Ratio28.97N/A-
RevenueN/A40.9K-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ZLDAF: Fundamental Ratings
ZLDAF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAVS0.88N/A
-0.08%
Paranovus Entertainment Technology Ltd
EPR56.55-0.93
-1.62%
EPR Properties
CHKP218.93-4.02
-1.80%
Check Point Software Technologies Ltd
ELDN2.87-0.13
-4.33%
Eledon Pharmaceuticals
IMXI10.28-0.62
-5.69%
International Money Express

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with CLDI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
CLDI - VBIZF
34%
Loosely correlated
+0.47%
SPHRY - VBIZF
11%
Poorly correlated
N/A
WXXWY - VBIZF
3%
Poorly correlated
-2.68%
UCBJF - VBIZF
3%
Poorly correlated
+2.55%
ZLDAF - VBIZF
2%
Poorly correlated
N/A
More

ZLDAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with BMEA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
N/A
BMEA - ZLDAF
37%
Loosely correlated
-9.58%
QLGN - ZLDAF
33%
Loosely correlated
-2.88%
SCNI - ZLDAF
32%
Poorly correlated
-4.72%
LYEL - ZLDAF
27%
Poorly correlated
N/A
YECO - ZLDAF
26%
Poorly correlated
N/A
More